Next Article in Journal
2017: A Fruitful Year for Pharmaceuticals
Previous Article in Journal
25th Conference of GP2A
Article Menu
Issue 4 (December) cover image

Export Article

Open AccessArticle
Pharmaceuticals 2017, 10(4), 99;

Convenient Preparation of 18F-Labeled Peptide Probes for Potential Claudin-4 PET Imaging

Department of Chemistry, Biochemistry, Zülpicher Str. 47a, 50674 Cologne, Germany
Institute of Neuroscience and Medicine, INM-5: Nuclear Chemistry, Forschungszentrum Jülich GmbH, Wilhelm-Johnen Str., 52425 Jülich, Germany
Institute of Radiochemistry and Experimental Molecular Imaging, University Clinic Cologne, Kerpener Str. 62, 50937 Cologne, Germany
Max Planck Institute for Metabolism Research, Gleueler Str. 50, 50931 Cologne, Germany
These authors contributed equally to this work.
Authors to whom correspondence should be addressed.
Received: 8 November 2017 / Revised: 8 December 2017 / Accepted: 13 December 2017 / Published: 18 December 2017
Full-Text   |   PDF [4158 KB, uploaded 18 December 2017]   |  


Since pancreatic cancer is often diagnosed in a late state of cancer development, diagnostic opportunities allowing early disease detection are highly sought after. As such, cancer expression of claudin proteins is markedly dysregulated, making it an attractive target for molecular imaging like positron emission tomography (PET). Claudins are a family of transmembrane proteins that have a pivotal role as members of the tight junctions. In particular, claudin-3 and claudin-4 are frequently overexpressed in pancreatic cancer. 18F-Labeled claudin selective peptides would provide access to a novel kind of imaging tools for pancreatic cancer. In this work we describe the synthesis of the first 18F-labeled probes potentially suitable for PET imaging of claudin-4 expression. These probes were prepared using oxime ligation of 5-[18F]fluoro-5-deoxyribose (5-[18F]FDR) to claudin selective peptides. As a proof-of-principle, one of them, 5-[18F]FDR-Clone 27, was isolated in >98% radiochemical purity and in 15% radiochemical yield (EOB) within 98 min, and with a molar activity of 4.0 GBq/μmol (for 30 MBq of tracer). Moreover, we present first biological data for the prepared 5-FDR-conjugates. These tracers could pave the way for an early diagnosis of pancreatic tumor, and thus improve the outcome of anticancer therapy. View Full-Text
Keywords: pancreatic cancer; PET-imaging; claudin receptors; targeting peptides; 5-[18F]FDR; 18F-labeling pancreatic cancer; PET-imaging; claudin receptors; targeting peptides; 5-[18F]FDR; 18F-labeling

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Feni, L.; Omrane, M.A.; Fischer, M.; Zlatopolskiy, B.D.; Neumaier, B.; Neundorf, I. Convenient Preparation of 18F-Labeled Peptide Probes for Potential Claudin-4 PET Imaging. Pharmaceuticals 2017, 10, 99.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top